This is a clinical trial to study and compare two drugs, chloroprocaine and bupivacaine for the benefits of patients undergoing short period of surgeries or day procedures who can be discharged early.

Spinal anaesthesia with hyperbaric bupivacaine and isobaric 1%-2chloroprocaine for short duration surgeries: Prospective randomized double blind comparative study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/013574

Enrollment

Registered

2018-05-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Below umbilicus surgeries, lower limb surgeries, anorectal surgeries Health Condition 2: O- Medical and Surgical Health Condition 3: O- Medical and Surgical

Interventions

Intervention1: Spinal anaesthesia given as a lumbar puncture into Sub-arachnoid space at L3-L3 or L3-L4 interspinous space.: Spinal Anaesthesia is the anesthetic technique used for surgical procedures

Eligibility

Inclusion criteria

Inclusion criteria: ASA I-III, Surgical procedures less than 60minutes ( 1 hour) , elective surgeries, below umbilicus procedures (lower limb, ano-rectal, urological, gynecological surgeries)

Exclusion criteria

Exclusion criteria: patients with contraindications to spinal anaesthesia ( Platelet count 1.5 , use of anti-coagulants, Spinal deformities,, sevre cardiac lesions) , age 70years, surgeries lasting more than 60minutes,n patients under ASA IV, V, E, patients allergic or intolerant to local anaesthetic agent, patients who are not willing to be included in the study.

Design outcomes

Primary

Measure	Time frame
The duration of sensory and motor blockade.Timepoint: 5 minutes to 4 hours	—

Secondary

Measure	Time frame
peak level of blockade, time until ambulation, time to reach eligibility criteria for discharge, complications like transient neurological symptoms (TNS)Timepoint: 5minutes to 12 hours	—

Countries

India

Contacts

Public ContactValluri Tejasree

Gayatri Vidya parishad institute of health care and medical technology

drvalluritejasree@gmail.com9949034599

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026